Johnson & Johnson on Tuesday lifted its 2025 revenue guidance after posting stronger-than-expected third-quarter earnings and revealed plans to spin off its orthopedics business into a standalone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback